To be fair to konameh, BUD has stated that they expect revenue growth off 70+% for the consumer business. To achieve that the Sep qtr would need to be over $20m or the Dec qtr will have to make up the shortfall.
From 31 July 2019:
This result is in line with expectations of year on year revenue growth of 70+%, with the second half of the year typically being the period when new retailers are onboarded, new products are released, cost reductions in the bill of materials (“BOM”) are realised, and the “snowball effect” of a growing customer base results in even just organic growth having a materially larger effect on unit sales.
I suspect that they are currently below 70% revenue growth.
- Forums
- ASX - By Stock
- BUD
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-32
Featured News
Add BUD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online